BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

ImmunityBio (NASDAQ:IBRX)

3 posts

Biotech NewsIs it Still Worthy to Buy ImmunityBio (IBRX) Shares?

  • BioTech Health X
  • February 8, 2026
We recently published our article Top 5 Best Biotech Stocks of February 2026. This piece looks at ImmunityBio…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Best Biotech Stocks of February 2026

  • BioTech Health X
  • February 8, 2026
In this article, we will take a look at the Top 5 Best Biotech Stocks of February 2026.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsImmunityBio (IBRX) Isn’t Chasing Hype—It’s Chasing Immune Memory

  • BioTech Health X
  • January 18, 2026
Founded at the intersection of immunology, oncology, and infectious disease research, this company was established with a singular…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • ADMA Biologics (ADMA): #1 Biotech Stock Pick for February 2026
  • Here’s What Makes Biohaven (BHVN) a Smart Long-Term Buy
  • Is it a Wise Move to Acquire Compass Therapeutics (CMPX) Shares?
  • Is it Still Worthy to Buy ImmunityBio (IBRX) Shares?
  • Is it Still Safe to Invest in Veracyte (VCYT)?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • February 8, 2026
    ADMA Biologics (ADMA): #1 Biotech Stock Pick for February 2026
    • February 8, 2026
    Here’s What Makes Biohaven (BHVN) a Smart Long-Term Buy
    • February 8, 2026
    Is it a Wise Move to Acquire Compass Therapeutics (CMPX) Shares?
    • February 8, 2026
    Is it Still Worthy to Buy ImmunityBio (IBRX) Shares?
    • February 8, 2026
    Is it Still Safe to Invest in Veracyte (VCYT)?
Recent Posts
  • Is Ginkgo Bioworks (DNA) a Smart Long-Term Pick?
    • February 6, 2026
  • Here’s Why You Should Invest in Aethlon Medical (AEMD)
    • February 6, 2026
  • Here’s Why Wall Street Still Says Buy — Even as AbCellera (ABCL) Trades Like a Penny Stock
    • February 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (770)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top